Todd N Eagar

Author PubWeight™ 26.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009 5.20
2 Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 2006 2.68
3 Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol 2008 1.88
4 Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2005 1.34
5 Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Arch Neurol 2009 1.24
6 Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol 2010 1.13
7 Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation 2011 1.11
8 DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA 2009 1.07
9 DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. Cell Mol Neurobiol 2011 1.02
10 Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease. Vaccine 2010 1.00
11 Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. PLoS One 2011 0.97
12 Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol 2002 0.96
13 A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease. J Neuroimmunol 2012 0.94
14 Direct and consensual murine pupillary reflex metrics: establishing normative values. Auton Neurosci 2009 0.93
15 PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS One 2009 0.90
16 Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain 2010 0.86
17 Prion proteins: physiological functions and role in neurological disorders. J Neurol Sci 2007 0.83
18 Translational research in neurology and neuroscience 2010: multiple sclerosis. Arch Neurol 2010 0.79
19 B cells, antibodies, and tertiary lymphoid tissue in MS brains. Lancet Neurol 2008 0.77
20 DNA-based vaccines: the future of multiple sclerosis therapy? Expert Rev Neurother 2008 0.76
21 DNA plasmid vaccination for multiple sclerosis. Arch Neurol 2007 0.76
22 Reversible alopecia associated with glatiramer acetate. Arch Neurol 2010 0.75
23 Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis. Arch Neurol 2009 0.75